Latest Breaking News On - Inkef capital - Page 1 : comparemela.com

PROVABLE MARKETS: Securities Finance Execution and Post-Trade Platform Secures $8MM Series A Investment Round

PROVABLE MARKETS: Securities Finance Execution and Post-Trade Platform Secures $8MM Series A Investment Round
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Noord hollandNew yorkUnited statesSteve greenblattDerek pennHarry harrisonJohn fichthornExchange commissionMatt cohen coSecurities finance executionPost trade platform securesSecurities financeDialectic capital managementInkef capitalSecurities financingMatt cohen co founder

Provable Markets Raises $8M in Series A Funding

Provable Markets Raises $8M in Series A Funding
finsmes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finsmes.com Daily Mail and Mail on Sunday newspapers.

Noord hollandMatt cohenSteve greenblattJohn fichthornDerek pennProvable marketsSecurities financeDialectic capital managementInkef capitalSecurities lending

Provable Markets secures $8m in latest funding round | News

Provable Markets secures $8m in latest funding round | News
fow.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fow.com Daily Mail and Mail on Sunday newspapers.

Matt cohenProvable marketsNew york basedDialectic capital managementInkef capitalSecurities financing

Calypso Enters into Agreement to Be Acquired by Novartis

Calypso is a European biotech translating Interleukin-15 biology into medical breakthroughs by developing CALY-002, an anti-IL-15 monoclonal antibody, for an array of autoimmune indicationsThe acquisition of Calypso gives Novartis full rights to CALY-002, a pipeline-in-a-drug with potential in dermatology, gastro-in.

Noord hollandRichard siegelAlain vicariBernard coulieHead of immunology research at novartisGoodwin procterJjdc incCalypso biotechCeliac diseaseChief executive officerImmunology researchInkef capitalGilde healthcareFountain healthcare partnersJohnson innovation

Updated clinical safety and efficacy data for iOnctura s roginolisib presented at ESMO Immuno-Oncology Congress 2023

Updated clinical safety and efficacy data for iOnctura s roginolisib presented at ESMO Immuno-Oncology Congress 2023
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Noord hollandCatherine pickeringStefan klotterOncology congressB future health fundResponse evaluation criteriaSolid tumorsChief executive officerInkef capitalSchroders capitalFuture healthLassen sie